Evidence map›Paper›PMID 27659805›Full record

ArticleMycopathologia2017

A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.

Yongxuan Hu, Yanqing Hu, Yan Lu, Shiyun Huang, Kangxing Liu, Xue Han, Zuhao Mao, Zhong Wu, Xianyi Zhou

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Increasing Susceptibility of Drug-ResistantMolecules (Basel, Switzerland) · 2020
    Article
  3. Patient presentation, differential diagnosis, and management of penile lesions.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2019
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yongxuan HuDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China. huyongxuan2003@163.com.
Yanqing HuDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Yan LuDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Shiyun HuangDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Kangxing LiuDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Xue HanDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Zuhao MaoDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Zhong WuDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China.
Xianyi ZhouDepartment of Dermatology and Venerology, The 3rd Affiliated Hospital of Southern Medical University, 183 West Zhongshan Rd, Guangzhou, 510630, China. zxy1962@163.com.
Third Affiliated Hospital of Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is the most common pathogen that causes balanoposthitis. It often causes recurrence of symptoms probably due to its antifungal resistance. A significant number of balanitis Candida albicans isolates are resistant to azole and terbinafine antifungal agents in vitro. However, balanoposthitis caused by fluconazole- and terbinafine-resistant Candida albicans has rarely been reported. Here, we describe a case of a recurrent penile infection caused by fluconazole- and terbinafine-resistant Candida albicans, as well as the treatments administered to this patient. The isolate from the patient was tested for drug susceptibility in vitro. It was sensitive to itraconazole, voriconazole, clotrimazole and amphotericin B, but not to terbinafine and fluconazole. Thus, oral itraconazole was administrated to this patient with resistant Candida albicans penile infection. The symptoms were improved, and mycological examination result was negative. Follow-up treatment of this patient for 3 months showed no recurrence.

Indexed as

Drug Resistance, FungalAdultAntifungal AgentsCandida albicansCandidiasis, Chronic MucocutaneousFluconazoleHumansItraconazoleMaleMicrobial Sensitivity TestsMicrobiological TechniquesMolecular Diagnostic TechniquesNaphthalenesPenile DiseasesRecurrenceTerbinafineAntifungal AgentsFluconazoleItraconazoleNaphthalenesTerbinafineCandida albicansFluconazoleItraconazolePenile infectionResistanceTerbinafine

Identifiers

PMID27659805
OpenAlexW2522829520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.